comparemela.com

Page 11 - Fabio Chianelli News Today : Breaking News, Live Updates & Top Stories | Vimarsana

DiagnaMed Announces DTC Eligibility of Its Common Shares in the United States

TORONTO, May 17, 2023 DiagnaMed Holdings Corp. , a generative AI healthcare solutions company, is pleased to announce that its OTCQB-listed common shares under the symbol “DGNMF”. | May 17, 2023

United statesFabio chianelliHealth genNeither the canadian securities exchangeDiagnamed holdings corpClearing corporationRegulation services providerMed holdingsDepository trust companyDepository trustCanadian securities exchangeDiagnamed holdings corp stock exchangePress releaseYmbol dmed ca25245d1033

DiagnaMed Launches Health GenAI , a New Division for Generative AI Healthcare Solutions

Focused on Health GenAI and CERVAI™, a generative AI brain health platformTORONTO, May 10, 2023 DiagnaMed Holdings Corp. , a generative AI healthcare solutions company, is pleased to. | May 10, 2023

Fabio chianelliRegulation services providerHealth genNeither the canadian securities exchangeDiagnamed holdings corpMed holdingsCanadian securities exchangeDiagnamed holdings corp stock exchangePress releaseLeased dmed ca25245d1033

DiagnaMed Launches Health GenAI , a New Division for Generative AI Healthcare Solutions Seite 1

10.05.2023 - Focused on Health GenAI and CERVAI, a generative AI brain health platformTORONTO, May 10, 2023 (GLOBE NEWSWIRE) - DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED) (OTCQB: DGNMF), a generative AI healthcare solutions company, is . Seite 1

Fabio chianelliHealth genDiagnamed holdings

DiagnaMed Launches FormGPT io, a Generative AI Healthcare Solution

03.05.2023 - TORONTO, May 03, 2023 (GLOBE NEWSWIRE) - DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED) (OTCQB: DGNMF), a generative AI healthcare solutions company, is pleased to announce the launch of FormGPT.io, a generative AI data . Seite 1

Fabio chianelliDiagnamed holdings corpMed holdings

PharmaTher Holdings Submits Fast Track Application to FDA for KETARX™ (Ketamine) for the Treatment of Parkinson s Disease

TORONTO, May 02, 2023 PharmaTher Holdings Ltd. , a specialty pharmaceutical company, today announced the submission of a Fast Track Application to the U.S. Food and Drug Administration for. | May 2, 2023

Fabio chianelliPharmather holdings ltdRegulation services providerCompany or pharmatherNeither the canadian securities exchangeDrug administrationMother holdingsFast track applicationAccelerated approvalPriority reviewRolling reviewNew drug applicationTreating motor disordersLevodopa induced dyskinesiasFast trackCanadian securities exchange

vimarsana © 2020. All Rights Reserved.